Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Any dopamine agonist showed no clear difference in adverse events as N of participants with at least one adverse event compared with placebo (moderate certainty).
Amantadine showed no clear difference in adverse events as N of participants with at least one adverse event compared with placebo (moderate certainty).
The intervention showed no clear difference in total number of adverse events (withdrawals due to lack of effect)c (low certainty).
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): atrioventricular block compared with mexiletine (very low certainty).
Uterine artery embolization (UAE) probably leads to higher adverse events: minor post‐procedural complications within one year compared with surgery (moderate certainty).
Uterine artery embolization (UAE) showed no clear difference in adverse events: major post‐procedural complications within one year compared with surgery (moderate certainty).
It is very uncertain whether standard polyurethane plus sutureless securement devices changes adverse events assessed during catheter dwell and on product removal compared with standard polyurethane (very low certainty).
It is very uncertain whether standard polyurethane plus tissue adhesive changes adverse events assessed during catheter dwell and on product removal compared with standard polyurethane (very low certainty).
It is very uncertain whether summary of findings: Any alternative model of care changes adverse events/falls: proportion of residents with a fall at longest compared with usual care (very low certainty).
It is very uncertain whether summary of findings table ‐ Endoscopic sphincterotomy changes proportion of participants with ≥ 1 serious adverse events at 1 year compared with sham treatment (very low certainty).
It is very uncertain whether summary of findings table ‐ Endoscopic sphincterotomy changes proportion of participants with ≥ 1 serious adverse events at 1 year compared with endoscopic papillary balloon dilation (very low certainty).
It is very uncertain whether summary of findings table ‐ Antibiotics changes adverse events considered non‐serious (penicillin versus cefotaxime) compared with other antibiotics (very low certainty).
Dextrose gel showed no clear difference in adverse events# (e.g. choking or vomiting at time of administration) compared with placebo (moderate certainty).
It is very uncertain whether bioengineered devices changes adverse events assessed as: adverse events (serious and non‐serious) compared with standard techniques (very low certainty).
It is very uncertain whether heated tobacco use changes serious adverse events – measured by self‐report and medical records compared with cigarette smoking (very low certainty).